Glass House Brands Inc.
GLAS NYSE
SEC CIK 1848731
Follow Glass House Brands
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $182M | −$29.7M |
| FY24 | $200.9M | $519K |
| FY23 | $160.8M | −$98.3M |
| FY22 | $84.9M | −$32.9M |
| FY21 | $63.2M | −$43.1M |
| FY20 | $48.3M | −$16.7M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 42.3% | −9.1% | −16.3% |
| FY24 | 48.5% | 2.9% | 0.3% |
| FY23 | 50.3% | −30.8% | −61.1% |
| FY22 | 24.4% | −66.4% | −38.8% |
| FY21 | 25% | −57.2% | −68.2% |
| FY20 | 38.8% | −12.4% | −34.5% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$15.7M |
| FY24 | $18.1M |
| FY23 | $10.9M |
| FY22 | −$68.6M |
| FY21 | −$128.8M |
| FY20 | −$11.5M |
| FY19 | - |
- Glass House Brands
- Healthcare median
Show the numbers
| Year | Glass House Brands | Healthcare median |
|---|---|---|
| FY25 | −16.3% | −30.6% |
| FY24 | 0.3% | −47% |
| FY23 | −61.1% | −58% |
| FY22 | −38.8% | −80.4% |
| FY21 | −68.2% | −71.9% |
| FY20 | −34.5% | −62.2% |
| FY19 | - | −46.3% |